Metabolism and longevity

Metabolism is how your body turns food into everything it does. When it works well, it switches cleanly between fuels and keeps blood sugar in a healthy range; when it does not, the same machinery that ages the cell starts to slip. Metabolic health is one of the strongest threads through ageing biology.

Read at your level

The standard read.

Metabolism is how you process energy

Metabolism is the network of reactions that converts food and stored energy into the ATP that powers everything a cell does. The useful question is less “how fast” and more “how well regulated”: whether the body keeps fuel supply matched to demand and blood glucose within a healthy band.

That regulation is where metabolism meets ageing. The nutrient-sensing pathways that set the balance between growth and repair also govern metabolic health, which is why the two track together.

Blood sugar and insulin sensitivity

Insulin signals cells to take up glucose from the blood. Insulin sensitivity is how readily they respond; its decline — insulin resistance — leaves glucose elevated and forces the pancreas to compensate, and it sits upstream of much age-related metabolic disease. Keeping cells insulin-sensitive is one of the clearest shared goals of metabolic health.

Metabolic flexibility

Metabolic flexibility is the capacity to switch fuel use — between carbohydrate and fat — according to availability and demand. A flexible metabolism oxidises fat efficiently at rest and shifts to glucose under load; an inflexible one gets stuck, which is characteristic of insulin resistance and metabolic disease.

Muscle, body composition and metabolism

Body composition — how much muscle versus fat you carry — shapes metabolism. Skeletal muscle is the main site of glucose disposal, so preserving it supports insulin sensitivity, while the age-related loss of muscle (sarcopenia) and gain of fat push the other way. Muscle preservation is a metabolic goal, not only a strength one.

Why metabolic health tracks with aging

Metabolic health and ageing share machinery. The nutrient-sensing pathways that regulate fuel also set the growth-versus-maintenance balance, and interventions that improve metabolism — energy restriction, exercise, and drugs that mimic them — are among the most reliable ways to extend lifespan in laboratory species. The human evidence is about risk-factor and healthspan markers, not proven lifespan extension.

Watch alongside

Films beside this reading

The biogerontologists and physicians this topic draws on, in their own words. Each film was verified before it was listed. The full collection lives in the video library.

Rich RollFasting & Nutrition Protocols for Longevity & Disease Prevention w/ Valter Longo | Rich Roll PodcastValter Longo — who defined the fasting-mimicking diet — on fasting, protein and the eating patterns his lab studies for healthspan and disease, at length with Rich Roll.Why it belongs hereThe primary source on fasting-mimicking, in his own words rather than second-hand. Longo is unusually precise about what the research does and does not show.

Metabolic Health SummitFasting Mimicking Diet, longevity and age-related diseases | Valter Longo, PhD | The Metabolic LinkLongo’s conference talk on the fasting-mimicking diet and age-related disease — the mechanisms of periodic fasting, and the trials his group has run.Why it belongs hereThe academic-audience version: more mechanism, fewer questions, delivered to a scientific meeting.

The Proof with Simon HillProtein, Fasting, Cancer, and Longevity - with Valter Longo, PhD | The Proof Podcast EP 237Longo on genuinely contested territory — protein intake, fasting, cancer and longevity — where the muscle literature and the longevity literature pull in different directions.Why it belongs hereA rigorous host pressing a leading researcher on the real disagreements. Pairs well with the protein debates in the nutrition library.

Peter Attia MDThe discovery & first uses of rapamycin | Peter Attia, David Sabatini, & Matt KaeberleinThe origin story of rapamycin — found on Easter Island, later shown to inhibit the mTOR growth pathway — told with David Sabatini, who mapped mTOR, and Matt Kaeberlein, who studies it in ageing.Why it belongs hereA rare short segment with two of the people who built this field. The cleanest introduction to the most-studied longevity drug candidate — mechanism, not hype.

Rapamycin Longevity LabMatt Kaeberlein on Rapamycin Longevity Series | Lessons learned from 2 decades of Rapamycin researchMatt Kaeberlein’s own summary of two decades of rapamycin research — what the animal evidence shows, what is known about dose and risk, and how far the mechanism runs ahead of human outcome data.Why it belongs hereThe most complete, most sober account of rapamycin and ageing, from a lead researcher careful to separate what is established from what is hoped.

In this series

More in this series

The video library →

This section is educational reference material about the biology of ageing, drawn from the review literature and cited throughout. It is not medical advice, it is not tailored to anyone’s circumstances, and it makes no claim about any product sold on this site. Where the human evidence is thinner than the mechanism, the text says so.